4
Changes in Ownership
RxSight, Inc. Filed Acc 0000950170-23-064616
Director sold 500,000 shares at an average $27.18 ($13,590,750)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Tammenoms Bakker Juliet Director | 2023-11-14 | Sale | −100,000 | $27.13 | $2,712,590 | 894,313 | I: show line 1 in the form |
| Tammenoms Bakker Juliet Director | 2023-11-15 | Sale | −400,000 | $27.20 | $10,878,160 | 494,313 | I: show line 2 in the form |
| Open-market sales · 500,000 sh · avg $27.18 · $13,590,750 | |||||||
Loading xslF345X05/ownership.xml…